{"id":49899,"date":"2022-10-21T12:01:54","date_gmt":"2022-10-21T10:01:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/"},"modified":"2022-10-21T12:01:54","modified_gmt":"2022-10-21T10:01:54","slug":"acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/","title":{"rendered":"Acute Kidney Injury (AKI) Epidemiology Forecast Report, 2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4661509\/acute-kidney-injury-aki-epidemiology-forecast?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=75zfcd&amp;utm_campaign=1760317+-+Acute+Kidney+Injury+(AKI)+Epidemiology+Forecast+Report%2C+2032%3A+Focus+on+United+States%2C+Germany%2C+Spain%2C+Italy%2C+France%2C+United+Kingdom%2C+and+Japan&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Acute Kidney Injury (AKI) &#8211; Epidemiology Forecast &#8211; 2032&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221021005170\/en\/1609876\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221021005170\/en\/1609876\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis Acute Kidney Injury &#8211; Epidemiology Forecast- 2032&#8243; report delivers an in-depth understanding of the AKI, historical and forecasted epidemiology trends in the United States, the EU-5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.\n<\/p>\n<p>\nThe disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Incident Population of AKI in Hospitalized Patients, Mortality Adjusted Incident Population of AKI in Hospitalized Patients, Stage-specific Incident Population of AKI and, Age-specific Incident Population of AKI in the 7MM market covering the United States, EU-5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2019 to 2032.\n<\/p>\n<p>\n<strong>Country Wise Acute Kidney Injury Epidemiology<\/strong>\n<\/p>\n<ul>\n<li>\nThe epidemiology segment also provides the AKI epidemiology data and findings across the United States, the EU-5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.\n<\/li>\n<li>\nThe total Mortality-adjusted Incident Cases of AKI in the 7MM comprised of 6,470,038 cases in 2021 and are projected to increase during the forecast period.\n<\/li>\n<li>\nThe total Mortality-adjusted Incident Cases of AKI in the United States is 2,210,647 in 2021.\n<\/li>\n<li>\nThe US contributed to the largest incident population of AKI, accounting for ~ 34% of the 7MM in 2021.\n<\/li>\n<li>\nAmong the EU-5 countries, Germany accounted for the highest number of AKI cases, followed by France, whereas Spain accounted for the lowest cases in 2021.\n<\/li>\n<li>\nIn Japan, the total mortality-adjusted Incident Cases of AKI was 1,272,824 in 2021 and is anticipated to rise during the forecast period.\n<\/li>\n<li>\nThe stage-specific cases of AKI includes stage I, Stage II and, stage III. Out of which maximum cases were reported in stage I AKI followed by stage II and Stage III.\n<\/li>\n<\/ul>\n<p>\n<strong>Scope of the Report<\/strong>\n<\/p>\n<ul>\n<li>\nThe report covers the descriptive overview of AKI, explaining its causes, signs and symptoms, pathogenesis and currently available therapies.\n<\/li>\n<li>\nComprehensive insight has been provided into the AKI epidemiology and treatment.\n<\/li>\n<li>\nAdditionally, an all-inclusive account of both the current and emerging therapies for AKI are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape.\n<\/li>\n<li>\nA detailed review of AKI market; historical and forecasted is included in the report, covering the 7MM drug outreach.\n<\/li>\n<li>\nThe report provides an edge while developing business strategies, by understanding trends shaping and driving the 7MM AKI market.\n<\/li>\n<\/ul>\n<p>\n<strong>Report Highlights<\/strong>\n<\/p>\n<ul>\n<li>\nIn the coming years, AKI market is set to change due emerging therapies in the pipeline, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market.\n<\/li>\n<li>\nThe companies and academics are working to assess challenges and seek opportunities that could influence AKI R&amp;D. The therapies under development are focused on novel approaches to treat\/improve the disease condition.\n<\/li>\n<li>\nAs per the analysis the subtypes- specific of AKI include Stage I, Stage II and Stage III.\n<\/li>\n<\/ul>\n<p>\n<strong>Epidemiology Insights:<\/strong>\n<\/p>\n<ul>\n<li>\nWhat is the disease risk, burden and unmet needs of AKI?\n<\/li>\n<li>\nWhat is the historical AKI patient pool in the United States, the EU-5 (Germany, France, Italy, Spain, and the UK) and Japan?\n<\/li>\n<li>\nWhat would be the forecasted patient pool of AKI at the 7MM level?\n<\/li>\n<li>\nWhat will be the growth opportunities across the 7MM with respect to the patient population pertaining to AKI?\n<\/li>\n<li>\nOut of the above-mentioned countries, which country would have the highest incident population of AKI during the study period (2019-2032)?\n<\/li>\n<li>\nAt what CAGR the population is expected to grow across the 7MM during the study period (2019-2032)?\n<\/li>\n<\/ul>\n<p>\n<strong>Reasons to Buy<\/strong>\n<\/p>\n<ul>\n<li>\nThe report will help in developing business strategies by understanding trends shaping and driving the AKI.\n<\/li>\n<li>\nTo understand the future market competition in the AKI market and Insightful review of the SWOT analysis of AKI.\n<\/li>\n<li>\nOrganize sales and marketing efforts by identifying the best opportunities for AKI in the US, EU-5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.\n<\/li>\n<li>\nThe AKI Epidemiology Model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources.\n<\/li>\n<\/ul>\n<p>\n<strong>AKI Report Insights<\/strong>\n<\/p>\n<ul>\n<li>\nPatient Population\n<\/li>\n<li>\nTherapeutic Approaches\n<\/li>\n<li>\n7MM Coverage\n<\/li>\n<li>\nAKI Epidemiology Segmentation<\/p>\n<p>\n\u00a0\n<\/p>\n<p>\n\u00a0\n<\/p>\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Key Insights<\/strong>\n<\/p>\n<p>\n<strong>2. Report Introduction<\/strong>\n<\/p>\n<p>\n<strong>3. Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>4. Epidemiology And Methodology<\/strong>\n<\/p>\n<p>\n<strong>5. Disease Background And Overview<\/strong>\n<\/p>\n<p>\n5.1. Introduction\n<\/p>\n<p>\n5.2. Symptoms\n<\/p>\n<p>\n5.3. Types Of Acute Kidney Injury\n<\/p>\n<p>\n5.4. Stages Classification\n<\/p>\n<p>\n5.5. Risk Factors\n<\/p>\n<p>\n5.6. Etiology\n<\/p>\n<p>\n<strong>6. Epidemiology And Patient Population<\/strong>\n<\/p>\n<p>\n6.1. Key Findings\n<\/p>\n<p>\n6.2. Assumptions And Rationale\n<\/p>\n<p>\n6.2.1. United States\n<\/p>\n<p>\n6.2.2. Eu-5\n<\/p>\n<p>\n6.2.3. Japan\n<\/p>\n<p>\n6.3. Total Incidence Of Acute Kidney Injury (AKI) In Hospitalized Patients In The 7mm\n<\/p>\n<p>\n6.4. Total Mortality Adjusted Incident Population Of AKI In Hospitalized Patients In The 7mm\n<\/p>\n<p>\n6.5. The United States\n<\/p>\n<p>\n6.6. Eu-5\n<\/p>\n<p>\n6.7. Japan\n<\/p>\n<p>\n<strong>7. Appendix<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4661509\/acute-kidney-injury-aki-epidemiology-forecast?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=75zfcd&amp;utm_campaign=1760317+-+Acute+Kidney+Injury+(AKI)+Epidemiology+Forecast+Report%2C+2032%3A+Focus+on+United+States%2C+Germany%2C+Spain%2C+Italy%2C+France%2C+United+Kingdom%2C+and+Japan&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/v2bb3s<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;lt&#x6f;&#x3a;&#112;&#114;e&#x73;&#x73;&#64;&#114;e&#x73;&#x65;&#x61;&#114;ch&#x61;&#x6e;&#100;&#109;a&#x72;&#x6b;&#101;&#116;s&#x2e;&#x63;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">p&#114;&#x65;&#x73;&#x73;&#64;&#114;&#x65;&#x73;&#x65;a&#114;&#x63;&#x68;&#x61;n&#100;&#x6d;&#x61;&#x72;k&#101;&#x74;&#x73;&#x2e;c&#111;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Acute Kidney Injury (AKI) &#8211; Epidemiology Forecast &#8211; 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This Acute Kidney Injury &#8211; Epidemiology Forecast- 2032&#8243; report delivers an in-depth understanding of the AKI, historical and forecasted epidemiology trends in the United States, the EU-5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49899","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Acute Kidney Injury (AKI) Epidemiology Forecast Report, 2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acute Kidney Injury (AKI) Epidemiology Forecast Report, 2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Acute Kidney Injury (AKI) &#8211; Epidemiology Forecast &#8211; 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This Acute Kidney Injury &#8211; Epidemiology Forecast- 2032&#8243; report delivers an in-depth understanding of the AKI, historical and forecasted epidemiology trends in the United States, the EU-5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-21T10:01:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221021005170\/en\/1609876\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Acute Kidney Injury (AKI) Epidemiology Forecast Report, 2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-10-21T10:01:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/\"},\"wordCount\":853,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221021005170\\\/en\\\/1609876\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/\",\"name\":\"Acute Kidney Injury (AKI) Epidemiology Forecast Report, 2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221021005170\\\/en\\\/1609876\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-10-21T10:01:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221021005170\\\/en\\\/1609876\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221021005170\\\/en\\\/1609876\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acute Kidney Injury (AKI) Epidemiology Forecast Report, 2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acute Kidney Injury (AKI) Epidemiology Forecast Report, 2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Acute Kidney Injury (AKI) Epidemiology Forecast Report, 2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Acute Kidney Injury (AKI) &#8211; Epidemiology Forecast &#8211; 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This Acute Kidney Injury &#8211; Epidemiology Forecast- 2032&#8243; report delivers an in-depth understanding of the AKI, historical and forecasted epidemiology trends in the United States, the EU-5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-21T10:01:54+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221021005170\/en\/1609876\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Acute Kidney Injury (AKI) Epidemiology Forecast Report, 2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan &#8211; ResearchAndMarkets.com","datePublished":"2022-10-21T10:01:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/"},"wordCount":853,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221021005170\/en\/1609876\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/","name":"Acute Kidney Injury (AKI) Epidemiology Forecast Report, 2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221021005170\/en\/1609876\/21\/logo.jpg","datePublished":"2022-10-21T10:01:54+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221021005170\/en\/1609876\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221021005170\/en\/1609876\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/acute-kidney-injury-aki-epidemiology-forecast-report-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Acute Kidney Injury (AKI) Epidemiology Forecast Report, 2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49899","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49899"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49899\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49899"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49899"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49899"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}